This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (571)

Published on in Vol 9, No 2 (2020): February

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17082, first published .
Adjuvant Alpha-Fetoprotein-Derived Peptide After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: Protocol for a Safety Study

Adjuvant Alpha-Fetoprotein-Derived Peptide After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: Protocol for a Safety Study

Adjuvant Alpha-Fetoprotein-Derived Peptide After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: Protocol for a Safety Study

Authors of this article:

Akihiro Nomura1 Author Orcid Image ;   Takeshi Terashima2 Author Orcid Image ;   Eishiro Mizukoshi2 Author Orcid Image ;   Masaaki Kitahara2 Author Orcid Image ;   Toshinori Murayama1 Author Orcid Image ;   Shuichi Kaneko2 Author Orcid Image
Article Authors Cited by Tweetations (1) Metrics

Akihiro Nomura   1 , MD, PhD ;   Takeshi Terashima   2 , MD, PhD ;   Eishiro Mizukoshi   2 , MD, PhD ;   Masaaki Kitahara   2 , MD, PhD ;   Toshinori Murayama   1 , MD, PhD ;   Shuichi Kaneko   2 , MD, PhD

1 Innovative Clinical Research Center, Kanazawa University, Kanazawa, Japan

2 Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan

Corresponding Author: